We are live on ! Find out more
BMY icon

Bristol-Myers Squibb

2,214 hedge funds and large institutions have $100B invested in Bristol-Myers Squibb in 2020 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 889 increasing their positions, 917 reducing their positions, and 89 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 109 | Existing positions closed: 89

1% more funds holding

Funds holding: 2,185 → 2,214 (+29)

0.01% less ownership

Funds ownership: 73.96% → 73.95% (-0.01%)

3% less repeat investments, than reductions

Existing positions increased: 889 | Existing positions reduced: 917

5% less capital inflows, than outflows

Capital inflows: $5.49B | Capital outflows: $5.76B

6% less call options, than puts

Call options by funds: $1.39B | Put options by funds: $1.48B

15% less funds holding in top 10

Funds holding in top 10: 110 → 93 (-17)

Holders
2,214
Holders Change
+29
Holders Change %
+1.33%
% of All Funds
44.54%
Holding in Top 10
93
Holding in Top 10 Change
-17
Holding in Top 10 Change %
-15.45%
% of All Funds
1.87%
New
109
Increased
889
Reduced
917
Closed
89
Calls
$1.39​B
Puts
$1.48​B
Net Calls
-⁠$90.4​M
Net Calls Change
+$47.9​M

BMY Hedge Fund Activity: Q3 2020 in Review

2,214 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q3 2020, worth a combined $100B — up 2.3% from $98.2B a quarter earlier.

Buyers outnumbered sellers: 109 funds opened new BMY positions and 89 closed out — a net gain of 20 holders — while 889 added to existing stakes and 917 trimmed.

The largest buyer was Berkshire Hathaway, opening a new position worth an estimated $1.8B. The largest seller was Renaissance Technologies, cutting an estimated $778M.

  • 2,214 institutional investors held Bristol-Myers Squibb (BMY) as of Q3 2020, up from 2,185 in Q2 2020.
  • Funds reported $100B of Bristol-Myers Squibb stock for Q3 2020, up 2.3% quarter-over-quarter.
  • 109 funds opened new Bristol-Myers Squibb positions in Q3 2020 and 89 closed out, a net change of +20 holders.
  • The largest Bristol-Myers Squibb buyer in Q3 2020 was Berkshire Hathaway, an estimated $1.8B added.
  • The largest Bristol-Myers Squibb seller in Q3 2020 was Renaissance Technologies, an estimated $778M sold.

Based on aggregated 13F filings for Q3 2020.